Atrial fibrillation and thromboprophylaxis in heart failure: The need for patient-centered approaches to address adherence
- Publication Type:
- Journal Article
- Vascular Health and Risk Management, 2013, 9 (1), pp. 3 - 11
- Issue Date:
Files in This Item:
|Ferguson et al, 2013, Vasc Health Risk Manag 9, 3–11.pdf||Published Version||188.1 kB|
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Atrial fibrillation is a common arrhythmia in heart failure and a risk factor for stroke. Risk assessment tools can assist clinicians with decision making in the allocation of thromboprophylaxis. This review provides an overview of current validated risk assessment tools for atrial fibrillation and emphasizes the importance of tailoring individual risk and the importance of weighing the benefits of treatment. Further, this review provides details of innovative and patient-centered methods for ensuring optimal adherence to prescribed therapy. Prior to initiating oral anticoagulant therapy, a comprehensive risk assessment should include evaluation of associated cardiogeriatric conditions, potential for adherence to prescribed therapy, frailty, and functional and cognitive ability. © 2013 Ferguson et al, publisher and licensee Dove Medical Press Ltd.
Please use this identifier to cite or link to this item: